Advanced company searchLink opens in new window

BAXALTA UK INVESTMENTS LTD.

Company number 04491888

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
24 Jan 2023 GAZ2(A) Final Gazette dissolved via voluntary strike-off
13 Dec 2022 TM01 Termination of appointment of Mark Gibbons as a director on 8 November 2022
08 Nov 2022 GAZ1(A) First Gazette notice for voluntary strike-off
28 Oct 2022 DS01 Application to strike the company off the register
23 Aug 2022 AP01 Appointment of Ms Seyda Atadan Memis as a director on 1 August 2022
01 Jul 2022 CS01 Confirmation statement made on 1 July 2022 with no updates
27 Oct 2021 AA Full accounts made up to 31 December 2020
06 Jul 2021 CS01 Confirmation statement made on 23 June 2021 with no updates
30 Nov 2020 TM01 Termination of appointment of Nicholas Hugh Meryon Insall as a director on 30 November 2020
16 Nov 2020 AA Full accounts made up to 31 December 2019
23 Jun 2020 CS01 Confirmation statement made on 23 June 2020 with updates
28 Apr 2020 CH04 Secretary's details changed for Shire Corporate Services Limited on 28 April 2020
07 Feb 2020 CH01 Director's details changed for Mr Jonathan Clark Neal on 6 February 2020
05 Dec 2019 AUD Auditor's resignation
27 Nov 2019 RESOLUTIONS Resolutions
  • RES10 ‐ Resolution of allotment of securities
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES01 ‐ Resolution of alteration of Articles of Association
26 Nov 2019 SH01 Statement of capital following an allotment of shares on 30 September 2019
  • GBP 7,000,100
26 Nov 2019 SH20 Statement by Directors
26 Nov 2019 SH19 Statement of capital on 26 November 2019
  • GBP 1
26 Nov 2019 CAP-SS Solvency Statement dated 25/11/19
26 Nov 2019 RESOLUTIONS Resolutions
  • RES13 ‐ Cancellation of share premium account 25/11/2019
  • RES06 ‐ Resolution of reduction in issued share capital
10 Oct 2019 AA Full accounts made up to 31 December 2018
05 Jul 2019 CS01 Confirmation statement made on 23 June 2019 with no updates
29 May 2019 TM01 Termination of appointment of Damien Rodolphe Edmond Bailly as a director on 6 May 2019
13 Mar 2019 AP01 Appointment of Mr Jonathan Clark Neal as a director on 12 March 2019
05 Feb 2019 PSC02 Notification of Takeda Pharmaceutical Company Limited as a person with significant control on 8 January 2019